Unity Biotechnology
UBX
#9701
Rank
S$27.83 M
Marketcap
$1.52
Share price
-8.13%
Change (1 day)
-40.98%
Change (1 year)

P/E ratio for Unity Biotechnology (UBX)

P/E ratio as of December 2024 (TTM): -0.2846

According to Unity Biotechnology 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.284635. At the end of 2022 the company had a P/E ratio of -0.3881.

P/E ratio history for Unity Biotechnology from 2018 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-0.3881-71.11%
2021-1.34-52.32%
2020-2.82-25.76%
2019-3.79-50.41%
2018-7.65

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-4.40 1,447.13%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.